CNS & Neurological Disorders-Drug Targets

Article	Citations
Meet the Editorial Board Member	128
Meet the Regional Editor	86
Neurobiology of Amphetamine use in Stroke Recovery Combined with Rehabilitative Training and Brain Stimulation	72
Memory Reflections of the Microbiota-Gut and Oligodendrocyte Axis	68
Breaking Barriers: Advanced Pharmacological Mediators for Neuropsychiatric Disorders	66
Hypomyelination with Atrophy of Basal Ganglia and Cerebellum (HABC) Due to UFM1 Mutation in Roma Patients - Severe Early Encephalopathy with Stridor and Severe Hearing and Visual Impairment. A Single	41
The Natural Neuroprotective Compounds Used in the 6-Hydroxydopamine- Induced Parkinson’s Disease in Zebrafish: The Current Applications and Perspectives	40
Na+/HCO3− Co-transporters Inhibitor S0859 Attenuates Global Cerebral Ischemia-reperfusion Injury of the CA1 Neurons in the Gerbil’s Hippocampus	40
The Potential Effect of Blueberry on Cognitive Health and Mood State based on Human Intervention Studies: Systematic Review and Mini Meta-Analysis	39
CRISPR/Cas9 Gene Editing: A Novel Approach Towards Alzheimer's Disease Treatment	38
Recent Trends in Physical Therapy Interventions and Neuromodulation Techniques to Improve Neurorehabilitation	37
Targeting JNK3: An In-silico Approach to Uncover Potential Therapeutics for Alzheimer’s Disease	33
Emerging Nanotechnology for the Treatment of Alzheimer’s Disease	31
Recent Advancement of Pyrazole Scaffold Based Neuroprotective Agents: A Review	30
Unravelling the Role of Tyrosine and Tyrosine Hydroxylase in Parkinson’s Disease: Exploring Nanoparticle-based Gene Therapies	30
Molecular and Biochemical Pathways Encompassing Diabetes Mellitus and Dementia	29
Unraveling the Triad: A Bioinformatics Analysis of the Interplay between Prenatal Depression, Inflammation, and the Gut Microbiota	29
Monoamine Oxidase: A Potential Link in Papez Circuit to Generalized Anxiety Disorders	28
From Microbes to Minds: The Impact of Gut Bacteria on Infant Cognitive Growth	26
AI-Driven Biomarker Discovery in Motor-Related Neurodegenerative Diseases	25
Precision Neurodegeneration: Integrating Molecular Mechanisms, Biomarkers, and Targeted Therapeutics	25
Danshensu Enhances Cerebral Angiogenesis in Mice by Regulating the PI3K/Akt/Mtor/VEGF Signaling Axis	24
The Emerging Role of Marine Natural Products for the Treatment of Parkinson’s Disease	24
Insights into the Diagnosis, Treatment, and Management of Prion Diseases	24
GFAP and UCHL1 in Non-traumatic SAH: The Story thus Far. A Systematic Review of the Literature	23

Cholinesterase Inhibitory and In Silico Toxicity Assessment of Thirty-Four Isoquinoline Alkaloids - Berberine as the Lead Compound	22
Clozapine in a Young Female with Drug-Resistant Schizophrenia: A Case Report of Development of Serositis	20
Gut-Brain Axis and Neurological Disorders-How Microbiomes Affect our Mental Health	20
Are Lysosomes Potential Therapeutic Targets for Parkinson’s Disease?	20
Microbiota-Gut-Brain Axis: A Novel Paradigm in the Neurobiology of Anxiety	20
Breaking Through Barriers: The Transformative Potential of Nanomedicine in Overcoming Drug Delivery Challenges for Psychiatric Disorders	20
Pathological Insights into Neurodegenerative and Neurodevelopmental Disorders: Perspectives for the Development of Novel Treatment Approaches	20
A Systematic Review of Updated Mechanistic Insights Towards Alzheimer’s Disease	19
A Critical Analysis of Quercetin as the Attractive Target for the Treatment of Parkinson's Disease	19
Black phosphorus in neurological disorders: Current therapeutic applications, mechanisms, and future prospects	18
WITHDRAWN: Nigella Fixed Oil Mitigates Memory Impairment in a Rat-Aged Model of Cognitive Decline; A Pivotal Role of BDNF and CREB Signaling Pathways in the Hippocampus	18
IL-33 is Required for Behavioral Deficits in a Murine Model of Systemic Lupus Erythematosus Through Regulation of Microglia Glycolysis	18
An Overview of the Natural Neuroprotective Agents for the Management of Cognitive Impairment Induced by Scopolamine in Zebrafish (Danio rerio)	17
Modulating the Microbiota-gut-brain Axis: A Promising Strategy for Alzheimer’s Disease Prevention and Management	17
Analysis of Concentrations of Monomethyl Fumarate in Patients with Multiple Sclerosis: Result from Routine Health Care	17
Nanoformulations: A Progressive Strategy for Alleviating Migraine through Nasal Route	17
Solid Lipid Nanoparticle Mediated Intranasal Drug Delivery for Brain Targeting: A Comprehensive Review	17
Vasospasm in Pediatric Subarachnoid Hemorrhage	17
Genetic Predisposition and Severity of Eating Disorders- A Review	16
Induced Depressive Disorder Following the First Dose of COVID-19 Vaccine	16
Effects of GABAergic Agents on Multiple Sclerosis. A Narrative Review of In-vivo Models	16
Endothelial-to-mesenchymal Transition at the Blood–brain Barrier: Molecular Mechanisms and Pathological Roles Across Brain Diseases	16
Navigated Transcranial Magnetic Stimulation (nTMS) based Preoperative Planning for Brain Tumor Treatment	16
Evolutionary Unmasking Resuscitative Therapeutics Potential of Centhaquin Citrate in Hypovolemic Shock	15
Impact of Structured Physical Exercise on Adolescent Depression: A Comprehensive Meta-Analysis of RCTs	15
Epilepsy: Modern Treatment Approaches, Clinical Aspects, and Patent Status	15
Targeting Blood-Brain Barrier Damage with Nanotechnology in the Fight Against Neurodegenerative Diseases	15
Obesity and Depression: Common Link and Possible Targets	15
Fisetin and Neurodegeneration: From Preclinical Studies to Potential Clinical Applications	15
Exploring the Potential of Herbal Compounds as Autophagy Modulators in Alzheimer's Disease: A Comprehensive Review	15
Comparison of the Sedative Effect of Ketamine, Magnesium Sulfate, and Propofol in Patients Undergoing Upper Gastrointestinal Endoscopy: Double-Blinded Randomized Clinical Trial	14
Role of Cholesterol Metabolism in the Link Between Diabetes and Alzheimer's Disease	14
Transcription Factor Pet-1/FEV as a Potential Therapeutic Target in Anxiety and Depressive Disorders	14
Natural Products as Bioactive Agents in the Prevention of Dementia	14
An Updated Review of Epigenetic-Related Mechanisms and their Contribution to Multiple Sclerosis Disease	14
Effect of Dual-task Exercise on Cognition and Dual-task Cost in the Elderly with Mild Cognitive Impairment: A Randomized Pilot Study	14
Neuroprotective and Anti-Inflammatory Effects of Pioglitazone on Parkinson's Disease: A Comprehensive Narrative Review of Clinical and Experimental Findings	14
Decoding the Gut-Brain Axis in Alzheimer's Disease: Emerging Perspectives	14
The Landscape of Randomized Clinical Trial Meta-analyses on Statins for Aneurysmal Subarachnoid Hemorrhage: A Scoping Review	14
Circadian Rhythm and Risk of Hemorrhagic Transformation after Acute Ischemic Stroke Treated with Intravenous Thrombolysis - A Systematic Review	13
Sweroside Modulates Oxidative Stress and Neuroplasticity-Related Gene Expression in Scopolamine-Treated Zebrafish	13
Effects of Hesperetin Early Intervention on Brain Neurons and Microglia in APPswe/PS1dE9 Mice	13
The Effect of a Novel Antibody-based Drug, Prospekta, on Brain Electrical Activity in Mice	13
COVID-19, the Brain, and the Future: Is Infection by the Novel Coronavirus a Harbinger of Neurodegeneration?	13
Acknowledgements to Reviewers	13
Role of G-Proteins and GPCR-Mediated Signalling in Neuropathophysiology	13
Tetrandrine Attenuates Cerebral Ischemia/Reperfusion Injury by Regulating Th17/Treg Balance and Mediating PI3K/Akt Pathway in Mice, Based on Network Pharmacology Analysis	12
Mechanism of Glioblastoma Treatment Targeting Growth Factors: IGF-I Case Using Gene, Immune, Phytochemicals, and Nanotechnologies	12
Bis-iodine-labeled Curcumin as a Potential CT Imaging Agent for β-amyloid Plaques in the Brain	12
Phosphodiesterase 2 and Its Isoform A as Therapeutic Targets in the Central Nervous System Disorders	12

Emerging Treatments for Subarachnoid Hemorrhage	12
Exosomes in Neurodegenerative Disorders: Isolation Strategies, Therapeutic Potential, and Clinical Trials	11
Rethinking Catatonia: New Insights from the Autism Spectrum	11
One-Trial Appetitive Learning Tasks for Drug Targeting	11
Cannabidiol in Epilepsy: Restoring Locomotion and Seizure Control	11
Acknowledgements to Reviewers	11
Inhibiting Monoamine Oxidase in CNS and CVS would be a Promising Approach to Mitigating Cardiovascular Complications in Neurodegenerative Disorders	11
Insights into the Molecular Mechanisms of Neurodegenerative Diseases: Exploring Molecular Pathways and the Therapeutic Potential of Rivastigmine	11
The Potential Role of Dopamine Pathways in the Pathophysiology of Depression: Current Advances and Future Aspects	11
Focused Ultrasound-activated Extracellular Vesicles–nanoparticle Hybrids for Targeted Brain Drug Delivery: Engineering Strategies and Translational Outlook	11
Prospects for Neurotrophic Factor-Based Early Intervention in Schizophrenia: Lessons Learned from the Effects of Antipsychotic Drugs on Cognition, Neurogenesis, and Neurotrophic Factors	11
Pharmacotherapy in SAH: Clinical Trial Lessons	11
Nanoparticle-Based Approaches for Glioblastoma Treatment: Advances and Future Prospects	10
Valproate Exposure as an In vitro Model for Studying Morpho-Molecular Features of ASD: A Systematic Review	10
Rationalizing the Use of Polyphenol Nano-formulations in the Therapy of Neurodegenerative Diseases	10
Neuroprotection or Sex Bias: A Protective Response to Traumatic Brain Injury in the Females	10
Lithium Chloride Rescues Dopaminergic Neurons in a Parkinson’s Disease Rat Model Challenged with Rotenone	10
Effectiveness of Highly Purified Cannabidiol in Refractory and Super-Refractory Status Epilepticus: A Case Series	10
Neurological Manifestations Following Traumatic Brain Injury: Role of Behavioral, Neuroinflammation, Excitotoxicity, Nrf-2 and Nitric Oxide	10
Lorcaserin: Worthy of Further Insights? Results from Recent Research	10
WITHDRAWN: Neurological Studies Of Herbal Medicinal Plants For The Treatment Of Memory Impairment: A Review	10
Stroke and Vascular Cognitive Impairment: The Role of Intestinal Microbiota Metabolite TMAO	10
Linking Neurodegeneration and Age-related Macular Degeneration: Unified Pathways and Intervention Strategies	9
Design and Molecular Docking Studies of N-Mannich Base Derivatives of Primaquine Bearing Isatin on the Targets involved in the Pathophysiology of Cerebral Malaria	9
Neurological Complications Caused by Human Immunodeficiency Virus (HIV) and Associated Opportunistic Co-infections: A Review on their Diagnosis and Therapeutic Insights	9
Circular RNAs in Alzheimer’s Disease: A New Perspective of Diagnostic and Therapeutic Targets	9
Benzodiazepines and Sleep Architecture: A Systematic Review	9
Endophenotypes and Pathway Phenotypes in Neuro-psychiatry: Crossdisciplinary Implications for Diagnosis	9
Therapeutic Potential of Myricetin in the Treatment of Neurological, Neuropsychiatric, and Neurodegenerative Disorders	9
Rationale and Development of Tavapadon, a D1/D5-Selective Partial Dopamine Agonist for the Treatment of Parkinson’s Disease	9
Nicotine Abuse and Neurodegeneration: Novel Pharmacogenetic Targets to Aid Quitting and Reduce the Risk of Dementia	9
An Insight into the Role of Artificial Intelligence in the Early Diagnosis of Alzheimer’s Disease	9
The Peripheral Profile of the Chitinase 3-like-1 in Benign Multiple Sclerosis – A Single Centre’s Experience	9
Nanotechnological Advances in the Treatment of Epilepsy	9
Traumatic Brain Injury in COVID-19 Patients with the Manifestation of Paroxysmal Sympathetic Hyperactivity and Cytokine Storm	9
Atorvastatin's Reduction of Alzheimer's Disease and Possible Alteration of Cognitive Function in Midlife as well as its Treatment	9
Challenges in Brain Drug Delivery for Neurodegenerative Disorders and Recent Trends: A Review	9
The Protective Role of L-carnitine on Psychosocial Stress-induced Changes in Gene Expression and Protein Levels of Matrix Metalloproteinases, Serum Corticosterone in a Rat Model	9
Circadian Rhythms and Sleep Disorders Associated to Major Depressive Disorder: Pathophysiology and Therapeutic Opportunities	9
Therapeutic Potential of Nutritional Modulators in Traumatic Brain Injury: A Systematic Review	9
Anaesthesia-induced Changes in Genomic Expression Leading to Neurodegeneration	8
Preface	8
Acute Peripheral Facial Nerve Palsy in Children and Adolescents: Clinical Aspects and Treatment Modalities	8
Ameliorating Effects of Virgin Coconut Oil (VCO) on Nicotine Dependence and Quality of Life in Smokers	8
Role of Unani Polyherbal Formulations in the Treatment of Diseases with Special Reference to Neurodegenerative Disorders	8
Nicotine Dependence-Induced Withdrawal Syndrome: Mechanistic Insights and Therapeutic Implications	8
Bibliometric Analysis of Neutrophil Extracellular Traps in Stroke: Research Trends and Hotspots	8
Coenzyme Q10 in the Treatment of Attention Deficit Hyperactivity Disorder in Children: A Randomized Controlled Trial	8
Neurotoxicity of Endogenous Neurotoxin Salsolinol in Parkinson's Disease	8
Protective Effects of Memantine Against Acute Stress-Induced Fear Memory and Synaptic Dysfunction via NMDA Receptor Antagonism	8
Cyclodextrins-Phospholipids Complex Loaded Nanofibers for Improved Oral Bioavailability and Brain Targeting for Management of Stress and Anxiety	7
Peripheral Vascular Disease is Associated with Impaired Activities of Daily Living in the Elderly with Dementia: A Prospective Study	7
Integrating Synthesis, Pharmacological Activity, and Molecular Modeling to Explore 1,2,4-Triazine Fused Thiazolidin-4-one Derivatives as GABAA Receptor Modulators	7
Brain-Derived Neurotrophic Factor – The Protective Agent Against Neurological Disorders	7
In Schizophrenia, Chronic Fatigue Syndrome- and Fibromyalgia-Like Symptoms are Driven by Breakdown of the Paracellular Pathway with Increased Zonulin and Immune Activation-Associated Neurotoxicity	7
Lactose and Casein Cause Changes on Biomarkers of Oxidative Damage and Dysbiosis in an Experimental Model of Multiple Sclerosis	7
Targeting Vascular Dementia: Pharmacological Mechanisms and Therapeutic Strategies	7
The Role of Ca2+ Permeable AMPA Receptors in Neurodegeneration, Neurotoxicity, and Neuroinflammation	7
The Role of Helicobacter pylori CagA Protein in Inhibiting Amyloid Protein Aggregation	7
The Role of the cGAS-STING Pathway in Central Nervous System Diseases	7
Imbalance of Th1 and Th2 Cytokines and Stem Cell Therapy in Pathological Pain	7
An Insight into Medicinal Chemistry and SAR Studies of Cholinesterase and BACE-1 Inhibitors for Alzheimer's Disease	7
Flow Diversion for the Management of Posterior Circulation’s Intracranial Aneurysms	7
Foresee Novel Targets for Alzheimer’s Disease by Investigating Repurposed Drugs	7
Valproic Acid and Celecoxib Enhance the Effect of Temozolomide on Glioblastoma Cells	7
Neurodegenerative Disorders and the Current State, Pathophysiology, and Management of Parkinson’s Disease	7
Synergistic Roles of Neuropeptide S and Environmental Enrichment in Preclinical Huntington’s Disease Depression Models	7
Association between Frequency of Seizures and Number of Antiseizure Medications (ASM) in Patients with Epilepsy	7
KCNQ2 Channel as a Druggable Epilepsy Target: Advances in Pharmacological Modifiers	7
An Overview of Acute Flaccid Myelitis	7
Early Detection of Glioma: Investigating Inflammatory Markers (CRP), Kidney, and Liver Function	7
The Possible Protective Effect of Taurine on Bisphenol Induced Structural Changes on the Cerebral Cortex of Rats: Histological and Immunohistochemical Study	6
Gut Microbiota in Neuroinflammation, Neurodegenerative Disorders, and Neuropsychiatric Disorders: A Comprehensive Narrative Review	6
How Do Abnormalities in the Cerebrospinal Fluid Impact Neuropsychology with Progressing Age?	6
Abnormality of Voltage-Gated Sodium Channels in Disease Development of the Nervous System. A Review Article	6
Strategic Neurodelivery of Psychedelic Compounds: Bridging Molecular Pharmacology with Therapeutic Innovation in CNS Disorders	6
Preface	6
Early Anti-CD20 and CNS Penetrant BTK Inhibition to Enhance OPC-Driven Remyelination in Multiple Sclerosis	6
The Endocannabinoid System as a Biomarker for Diagnostic and Therapeutic Applications in Depression and Anxiety	6
Pre-clinical Aspects and Contemporary Treatments of Parkinson’s Disease	6

Ferroptosis Targeting Offers a Therapeutic Strategy for Subarachnoid Hemorrhage	6
Role of Lipocalin-2 in N1/N2 Neutrophil Polarization After Stroke	6
Metabolic Disorder Therapeutics and their Effects on Memory	6
Parkinson’s Disease: A Progressive Neurodegenerative Disorder and Structure-Activity Relationship of MAO Inhibitor Scaffolds as an Important Therapeutic Regimen	6
Meet the Editorial Board Member	6
Role of Imaging Genetics in Alzheimer’s Disease: A Systematic Review and Current Update	6
A Causal-Pathway Phenotype of Chronic Fatigue Syndrome due to Hemodialysis in Patients with End-Stage Renal Disease	6
Meet the Editorial Board Member	6
Syntaxin-4 at the Crossroads of Synaptic Plasticity and Neurodegeneration: From Molecular Mechanisms to Biomarker and Therapeutic Potential	6
Sleep-Related Disorders in Parkinson's Disease: Mechanisms, Diagnosis, and Therapeutic Approaches	5
Comparison of Safety and Effectiveness between Levetiracetam and Phenytoin in the Treatment of Pediatric Status Epilepticus: A Meta- Analysis	5
Role of Vitamins in Neurodegenerative Diseases: A Review	5
Implication of HPA-axis Dysfunction in Depression: From Neurobiological Mechanisms to Future Treatment Strategies	5
Dietary Xylitol Supplement Ameliorated AD-related Neuronal Injury by Regulating Glucose Metabolism Relevant Amino Acids in Mice	5
Cell-Free DNA, a Noninvasive Biomarker for Prediction and Detection of Neurodegenerative Diseases, New Insights, and Perspectives	5
Mitochondrial Dysfunction in Parkinson's Disease: Diagnostic and Therapeutic Advances	5
Notopterygium incisum Root Extract (NRE) Alleviates Epileptiform Symptoms in PTZ-Induced Acute Seizure Mice	5
WITHDRAWN: Neuroprotective Effect of 3,3′-Diindolylmethane and ɑ-Naphthoflavone, Aryl Hydrocarbon Receptor Modulators, in an Experimental Model of Ischemic Stroke	5
Cannabidiol in Digital Fatigue: Neuroadaptive Mechanisms and Therapeutic Perspectives on Chronic Screen Exposure	5
Pharmacogenetics of Carbamazepine: A Systematic Review on CYP3A4 and CYP3A5 Polymorphisms	5
Genetic Causes of Alzheimer’s Disease and the Neuroprotective Role of Melatonin in its Management	5
The Role of Monoamine Oxidase B Inhibitors in the Treatment of Parkinson’s Disease - An Update	5
A Comprehensive Review on Therapeutic Potential of Chrysin in Brain Related Disorders	5
Speech as a Biomarker for Depression	5
Recent Development of Zolmitriptan Formulation in Migraine Therapy: Production, Metabolism and Pharmaceutical Aspects	5
A Systematic Review of Recent Advances in Drug Delivery to the Central Nervous System Through Prodrug Approach	5
Neuroinflammation, Autophagy, and Neurodegeneration: Mechanisms and Therapeutic Insights	5
Recent Trends in Nano-Particulate Carriers for the Diagnosis and Treatment of Alzheimer’s Disease	5
Hypoxia-inducible Factor-1α Pathway in Cerebral Ischemia: From Molecular Mechanisms to Therapeutic Targets	5
Targeted Nanotechnology Approaches to Bypass the Blood–brain Barrier in Neurodegenerative Disorders	5
Clinical Benefits of Therapeutic Interventions Targeting Mitochondria in Parkinson’s Disease Patients	5
Exploring LRRK2-dependent Mechanisms in Parkinson’s Disease Therapy	5
Targeted Delivery of Montelukast for the Treatment of Alzheimer’s Disease	5
Nordihydroguaiaretic Acid Affects Undifferentiated and Differentiated Neuroblastoma Cells Differently through Mechanisms that Impact on Cell Viability	5
Dopamine Depletion in Parkinson’s Disease and Therapeutic Options	5
Ablation of Shank1 Protects against 6-OHDA-induced Cytotoxicity via PRDX3-mediated Inhibition of ER Stress in SN4741 Cells	5
From Anesthetic to Neuroprotector: Multi-Omics Reveals Ketamine's Previously Unexplored Neuroprotective Role in Alzheimer's Disease	5
Acknowledgements to Reviewers	5
β-Amyloid Pathways in Alzheimer's Disease: Mechanisms and Therapeutic Targets	5
Evaluation of Associated Genes with Traumatic Pain: A Systematic Review	5
Nanoparticles as Powerful Tools for Crossing the Blood-brain Barrier	5
Unraveling the Emerging Niche Role of Extracellular Vesicles (EVs) in Traumatic Brain Injury (TBI)	4
Pharmacology and Pharmacogenomics of Anti-Migraine Drugs	4
Comprehensive Perspective Towards the Management of Proteinopathies by Elucidating Protein Misfolding and Aggregation	4
Tirofiban-Nimodipine Combination Therapy for Early Neurological Deterioration in Small Artery Occlusion Stroke: A Retrospective Cohort Study	4
Meet the Frontier Section Editor	4
Oxytocin Effect in Adult Patients with Autism: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials	4
User-Centered Design of Neuroprosthetics: Advancements and Limitations	4
Pharmacological Breakthroughs with Extracellular Vesicles-Based Nanomedicine: A Targeted Strategy to Cross the Blood-Brain Barrier in Alzheimer’s Disease	4
The Use of Benzodiazepines and Risk of Incident Type 2 Diabetes in the General Population with Insomnia	4
Biotechnological Perspectives on GSK-3β and Hyperprolactinemia: Implications for the Progression of Alzheimer’s Disease	4
Re-Profiling and Re-purposing of FDA-Approved AntiViral Agents Against Neurological Targets of Memory and Cognition: Molecular Docking and Simulation Approach	4
APOE4 is a Risk Factor and Potential Therapeutic Target for Alzheimer's Disease	4
Dipsacoside B Exerts a Beneficial Effect on Brain Injury in the Ischemic Stroke Rat through Inhibition of Mitochondrial E3 Ubiquitin Ligase 1	4
Immunotherapeutic Approaches for the Treatment of Neurodegenerative Diseases: Challenges and Outcomes	4
Natural Compounds as Inhibitors of Aβ Peptide and Tau Aggregation	4
Nutritional Support System (NSS) as a New Therapeutic Strategy for Cerebral Palsy	4
Hypothesis-Driven Insights and Clinical Trial Updates in Alzheimer’s Disease Pathogenesis	4
The Effectiveness of Transcranial Magnetic Stimulation in Treating Apraxia	4
Hesperetin Early Intervention Reduces Β-Amyloid Production in APP/PS1 Mice by Decreasing Beta and Gamma-Secretase Enzyme	4
Role of Alpha-7-Nicotinic Acetylcholine Receptor in Alzheimer's Disease	4
A Comprehensive Study of miRNAs in Parkinson’s Disease: Diagnostics and Therapeutic Approaches	4
Fluoride-induced Neurodevelopmental Toxicity- AMPK as a Possible Target	4
The Participation of Ca2+ Channels in Epilepsy: A Bibliometric Analysis of the Scientific Literature in Latin America	4
Exploring Therapeutic Strategies: The Relationship between Metabolic Disorders and FOXO Signalling in Alzheimer's Disease	4
Subarachnoid Hemorrhage	4
Effect of Natural Plant Products on Alzheimer’s Disease	4
Immunotherapeutics for AD: A Work in Progress	4
Common microRNAs in Epilepsy and Migraine: Their Possibility as Candidates for Biomarkers and Therapeutic Targets during Comorbid Onset of Both Conditions	3
Meet the Associate Editorial Board Member	3
Preface	3
Research Progress on Intervention Strategies Targeting the Gut-Brain Axis in Alzheimer's Disease	3
L-Ala-L-Gln Suppresses Hypoxic Phenotype and Fibrogenic Activity of Rat Perineurial Fibroblasts	3
Meet the Co-Editor	3
A Potential Strategy for Treating Parkinson's Disease Through Intranasal Nanoemulsions	3
The Neuroprotective Role of BCG Vaccine in Movement Disorders: A Review	3
Modeling of Parkinson's Disease in Different Models	3
Reconnoitering the Potential of the Pharmacogenomics Approach in the Management of Alzheimer's Disease: A Review	3
Perspective on Cav-1 for its Potential as Newer Therapeutics for Parkinson’s Disease	3
Smartphone Addiction among Students and its Harmful Effects on Mental Health, Oxidative Stress, and Neurodegeneration towards Future Modulation of Anti-Addiction Therapies: A Comprehensive Survey base	3
Bcl-2 as a Double-edged Sword for the Treatment of Multiple Sclerosis: A Systematic Review	3
A Concise Review of Common Plant-derived Compounds as a Potential Therapy for Alzheimer's Disease and Parkinson's Disease: Insight into Structure-Activity-Relationship	3
Clinical Efficacy of Cerebrolysin and Cerebrolysin plus Nootropics in the Treatment of Patients with Acute Ischemic Stroke in Vietnam	3
Vitamin D and Neurological Health: Unraveling Risk Factors, Disease Progression, and Treatment Potential	3
Neuroprotective Potential of Bacopa monnieri: Modulation of Inflammatory Signals	3
Immune Cell Infiltration and Key Gene Identification in Alzheimer's Disease and Sleep Deprivation	3
Microbiome-Based Therapies in Parkinson’s Disease: Can Tuning the Microbiota Become a Viable Therapeutic Strategy?	3
Enhanced Neuroprotection in Experiment Multiple Sclerosis through Combined Rosiglitazone and Probiotic-loaded Solid Lipid Nanoparticles: Modulation of Cellular Signaling Pathways	3
Mechanistic Insights into Terpenoid-Based Therapy for Parkinson’s Disease	3
Role of Autophagy and Mitophagy in Neurodegenerative Disorders	3
Synergistic Neuroimmune Modulation by Cannabidiol and Probiotics for Therapeutic Advancement in CNS Disorders: A Systematic Review	3
Trends and Perspectives in the Rational Management of CNS Disorders	3
Reciprocal Interaction of Pain and Brain: Plasticity-induced Pain, Pain-induced Plasticity, and Therapeutic Targets	3
Neuroinflammatory and Synaptic Roles of Glial Cells in Autism Spectrum Disorder	3
Understanding the OMA1-DELE1-HRI Axis and PINK1-parkin-mediated Mitophagy in Parkinson’s Disease	3